

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | high-density lipoprotein particle remodeling (GO:0034375) | 8.98388721 |
| 2 | phospholipid efflux (GO:0033700) | 8.96091175 |
| 3 | regulation of triglyceride catabolic process (GO:0010896) | 7.92125547 |
| 4 | reverse cholesterol transport (GO:0043691) | 7.67986078 |
| 5 | plasma lipoprotein particle assembly (GO:0034377) | 7.06853529 |
| 6 | regulation of cholesterol esterification (GO:0010872) | 6.56318617 |
| 7 | very-low-density lipoprotein particle assembly (GO:0034379) | 6.38153336 |
| 8 | protein-lipid complex assembly (GO:0065005) | 6.31816235 |
| 9 | negative regulation of lipase activity (GO:0060192) | 6.20688914 |
| 10 | cholesterol efflux (GO:0033344) | 5.67186067 |
| 11 | plasma lipoprotein particle remodeling (GO:0034369) | 5.44468099 |
| 12 | protein-lipid complex remodeling (GO:0034368) | 5.44468099 |
| 13 | macromolecular complex remodeling (GO:0034367) | 5.44468099 |
| 14 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 5.26302451 |
| 15 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.18924231 |
| 16 | protein carboxylation (GO:0018214) | 5.18924231 |
| 17 | negative regulation of sterol transport (GO:0032372) | 4.53530367 |
| 18 | negative regulation of cholesterol transport (GO:0032375) | 4.53530367 |
| 19 | plasma lipoprotein particle clearance (GO:0034381) | 4.50367032 |
| 20 | xenobiotic catabolic process (GO:0042178) | 4.36350061 |
| 21 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.34320667 |
| 22 | transepithelial transport (GO:0070633) | 4.26813858 |
| 23 | water-soluble vitamin biosynthetic process (GO:0042364) | 4.26695901 |
| 24 | progesterone metabolic process (GO:0042448) | 4.23410600 |
| 25 | regulation of lipoprotein metabolic process (GO:0050746) | 4.18671999 |
| 26 | cellular response to zinc ion (GO:0071294) | 4.12668735 |
| 27 | galactose catabolic process (GO:0019388) | 4.10792786 |
| 28 | positive regulation of prostaglandin secretion (GO:0032308) | 4.07456153 |
| 29 | cellular response to exogenous dsRNA (GO:0071360) | 4.03841298 |
| 30 | regulation of metalloenzyme activity (GO:0048552) | 3.98750056 |
| 31 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.98259242 |
| 32 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.98259242 |
| 33 | plasma lipoprotein particle organization (GO:0071827) | 3.96701722 |
| 34 | membrane raft organization (GO:0031579) | 3.93721628 |
| 35 | galactose metabolic process (GO:0006012) | 3.85799632 |
| 36 | protein maturation by protein folding (GO:0022417) | 3.76897475 |
| 37 | protein-lipid complex subunit organization (GO:0071825) | 3.74569368 |
| 38 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.72399092 |
| 39 | 4-hydroxyproline metabolic process (GO:0019471) | 3.70649364 |
| 40 | membrane budding (GO:0006900) | 3.70244032 |
| 41 | L-ascorbic acid metabolic process (GO:0019852) | 3.66616218 |
| 42 | oligosaccharide catabolic process (GO:0009313) | 3.59439784 |
| 43 | lipoprotein transport (GO:0042953) | 3.59435504 |
| 44 | regulation of extracellular matrix disassembly (GO:0010715) | 3.59072775 |
| 45 | regulation of fatty acid biosynthetic process (GO:0042304) | 3.57775058 |
| 46 | regulation of lipoprotein particle clearance (GO:0010984) | 3.45328270 |
| 47 | proteasome assembly (GO:0043248) | 3.41421470 |
| 48 | regulation of triglyceride metabolic process (GO:0090207) | 3.29288994 |
| 49 | regulation of prostaglandin secretion (GO:0032306) | 3.29092128 |
| 50 | response to phenylpropanoid (GO:0080184) | 3.28271960 |
| 51 | glutathione derivative biosynthetic process (GO:1901687) | 3.26075691 |
| 52 | glutathione derivative metabolic process (GO:1901685) | 3.26075691 |
| 53 | removal of superoxide radicals (GO:0019430) | 3.25929872 |
| 54 | cellular response to superoxide (GO:0071451) | 3.25929872 |
| 55 | cellular response to oxygen radical (GO:0071450) | 3.25929872 |
| 56 | acylglycerol homeostasis (GO:0055090) | 3.25338956 |
| 57 | triglyceride homeostasis (GO:0070328) | 3.25338956 |
| 58 | polyol transport (GO:0015791) | 3.24831223 |
| 59 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.23060217 |
| 60 | sterol transport (GO:0015918) | 3.17099575 |
| 61 | cholesterol transport (GO:0030301) | 3.17099575 |
| 62 | positive regulation of protein targeting to membrane (GO:0090314) | 3.15746717 |
| 63 | negative regulation of receptor-mediated endocytosis (GO:0048261) | 3.10436254 |
| 64 | positive regulation of guanylate cyclase activity (GO:0031284) | 3.10244954 |
| 65 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.08360415 |
| 66 | nephron epithelium morphogenesis (GO:0072088) | 3.06980945 |
| 67 | nephron tubule morphogenesis (GO:0072078) | 3.06980945 |
| 68 | autophagic vacuole fusion (GO:0000046) | 3.05294107 |
| 69 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.94007151 |
| 70 | regulation of sterol transport (GO:0032371) | 2.92782714 |
| 71 | regulation of cholesterol transport (GO:0032374) | 2.92782714 |
| 72 | macrophage activation involved in immune response (GO:0002281) | 2.90117560 |
| 73 | C21-steroid hormone metabolic process (GO:0008207) | 2.89405357 |
| 74 | positive regulation of substrate adhesion-dependent cell spreading (GO:1900026) | 2.88282952 |
| 75 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.87723700 |
| 76 | negative regulation of fatty acid metabolic process (GO:0045922) | 2.86894966 |
| 77 | negative regulation of metanephros development (GO:0072217) | 2.86044638 |
| 78 | cellular response to interferon-beta (GO:0035458) | 2.85578115 |
| 79 | regulation of guanylate cyclase activity (GO:0031282) | 2.75614333 |
| 80 | organelle membrane fusion (GO:0090174) | 2.74052974 |
| 81 | cholesterol homeostasis (GO:0042632) | 2.71598523 |
| 82 | ribonucleoside diphosphate metabolic process (GO:0009185) | 2.68811005 |
| 83 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.68517635 |
| 84 | lipoprotein metabolic process (GO:0042157) | 2.67680690 |
| 85 | nucleoside diphosphate catabolic process (GO:0009134) | 2.67559910 |
| 86 | sterol homeostasis (GO:0055092) | 2.65851233 |
| 87 | positive regulation of lipid catabolic process (GO:0050996) | 2.65584790 |
| 88 | protein heterotetramerization (GO:0051290) | 2.64294362 |
| 89 | purine nucleoside diphosphate metabolic process (GO:0009135) | 2.64282394 |
| 90 | purine ribonucleoside diphosphate metabolic process (GO:0009179) | 2.64282394 |
| 91 | phototransduction, visible light (GO:0007603) | 2.63844840 |
| 92 | DNA damage response, detection of DNA damage (GO:0042769) | 2.59934610 |
| 93 | sleep (GO:0030431) | 2.59832817 |
| 94 | regulation of lipoprotein lipase activity (GO:0051004) | 2.59392584 |
| 95 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 2.56967531 |
| 96 | retinoid metabolic process (GO:0001523) | 2.56328061 |
| 97 | glucosamine-containing compound catabolic process (GO:1901072) | 2.55918092 |
| 98 | keratan sulfate catabolic process (GO:0042340) | 2.52680893 |
| 99 | regulation of substrate adhesion-dependent cell spreading (GO:1900024) | 2.52426069 |
| 100 | negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) | 2.51989723 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 5.98892610 |
| 2 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.80636478 |
| 3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.70672896 |
| 4 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.56778584 |
| 5 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.37403037 |
| 6 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.24807691 |
| 7 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.95222140 |
| 8 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.94886485 |
| 9 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.90745113 |
| 10 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.69581333 |
| 11 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.39779253 |
| 12 | TP53_16413492_ChIP-PET_HCT116_Human | 2.13813895 |
| 13 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.08136740 |
| 14 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.05615585 |
| 15 | GATA1_22025678_ChIP-Seq_K562_Human | 2.05113351 |
| 16 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.98338011 |
| 17 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.96717180 |
| 18 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.96211180 |
| 19 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.90007904 |
| 20 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.88029684 |
| 21 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.87829408 |
| 22 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.83274179 |
| 23 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.73216549 |
| 24 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.73155474 |
| 25 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.70611102 |
| 26 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.69825851 |
| 27 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.68256892 |
| 28 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.68133973 |
| 29 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.67830104 |
| 30 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.67547918 |
| 31 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.67547918 |
| 32 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.63326079 |
| 33 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.62009136 |
| 34 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.61169852 |
| 35 | VDR_22108803_ChIP-Seq_LS180_Human | 1.57633623 |
| 36 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.54292804 |
| 37 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.51542330 |
| 38 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.50514683 |
| 39 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.49531351 |
| 40 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.49264776 |
| 41 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.48539368 |
| 42 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.46038330 |
| 43 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.44892933 |
| 44 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.42219916 |
| 45 | ATF3_27146783_Chip-Seq_COLON_Human | 1.41146421 |
| 46 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.37962502 |
| 47 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.37547997 |
| 48 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.36947985 |
| 49 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.36947985 |
| 50 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.36692394 |
| 51 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.32745595 |
| 52 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.28080718 |
| 53 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.27216878 |
| 54 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 1.25849897 |
| 55 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.24216553 |
| 56 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.23990352 |
| 57 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 1.23360449 |
| 58 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 1.22907518 |
| 59 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.22567373 |
| 60 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.16076110 |
| 61 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.15629743 |
| 62 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.15360443 |
| 63 | RBPJ_21746931_ChIP-Seq_IB4_Human | 1.13339658 |
| 64 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.13128356 |
| 65 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.11760316 |
| 66 | SA1_27219007_Chip-Seq_Bcells_Human | 1.10878345 |
| 67 | CJUN_26792858_Chip-Seq_BT549_Human | 1.10298705 |
| 68 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.09117110 |
| 69 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.07368881 |
| 70 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.07248892 |
| 71 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 1.07008719 |
| 72 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 1.06876183 |
| 73 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.06582803 |
| 74 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.03054369 |
| 75 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.02996193 |
| 76 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.02297386 |
| 77 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.02089436 |
| 78 | P300_27268052_Chip-Seq_Bcells_Human | 1.02029333 |
| 79 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.01791778 |
| 80 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.01569990 |
| 81 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.00630484 |
| 82 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.99927638 |
| 83 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.99493595 |
| 84 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.95919908 |
| 85 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.95423875 |
| 86 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.94964464 |
| 87 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94960959 |
| 88 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.94919409 |
| 89 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.94330103 |
| 90 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.92441297 |
| 91 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.91371726 |
| 92 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.90516422 |
| 93 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.90087726 |
| 94 | CBP_21632823_ChIP-Seq_H3396_Human | 0.90087648 |
| 95 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.90016866 |
| 96 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.89424296 |
| 97 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.88818402 |
| 98 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.88637332 |
| 99 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.88627073 |
| 100 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.87363471 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009840_abnormal_foam_cell | 9.46318350 |
| 2 | MP0005360_urolithiasis | 7.23722504 |
| 3 | MP0003191_abnormal_cellular_cholesterol | 3.67004289 |
| 4 | MP0002139_abnormal_hepatobiliary_system | 2.88811414 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 2.80660435 |
| 6 | MP0004019_abnormal_vitamin_homeostasis | 2.75839917 |
| 7 | MP0010329_abnormal_lipoprotein_level | 2.65866136 |
| 8 | MP0003878_abnormal_ear_physiology | 2.56516694 |
| 9 | MP0005377_hearing/vestibular/ear_phenot | 2.56516694 |
| 10 | MP0002876_abnormal_thyroid_physiology | 2.30494320 |
| 11 | MP0003183_abnormal_peptide_metabolism | 2.13594567 |
| 12 | MP0005257_abnormal_intraocular_pressure | 2.11877971 |
| 13 | MP0004270_analgesia | 2.08295464 |
| 14 | MP0005084_abnormal_gallbladder_morpholo | 1.97908667 |
| 15 | MP0005083_abnormal_biliary_tract | 1.93868738 |
| 16 | MP0003252_abnormal_bile_duct | 1.83804037 |
| 17 | MP0002909_abnormal_adrenal_gland | 1.81950943 |
| 18 | MP0005332_abnormal_amino_acid | 1.81146660 |
| 19 | MP0003950_abnormal_plasma_membrane | 1.76415479 |
| 20 | MP0001666_abnormal_nutrient_absorption | 1.69679966 |
| 21 | MP0004145_abnormal_muscle_electrophysio | 1.64183722 |
| 22 | MP0001873_stomach_inflammation | 1.64147800 |
| 23 | MP0005365_abnormal_bile_salt | 1.49424562 |
| 24 | MP0004272_abnormal_basement_membrane | 1.44879772 |
| 25 | MP0005367_renal/urinary_system_phenotyp | 1.40879358 |
| 26 | MP0000516_abnormal_urinary_system | 1.40879358 |
| 27 | MP0005085_abnormal_gallbladder_physiolo | 1.40348912 |
| 28 | MP0005379_endocrine/exocrine_gland_phen | 1.39323982 |
| 29 | MP0000647_abnormal_sebaceous_gland | 1.36831277 |
| 30 | MP0010386_abnormal_urinary_bladder | 1.36033212 |
| 31 | MP0005165_increased_susceptibility_to | 1.35610081 |
| 32 | MP0003638_abnormal_response/metabolism_ | 1.29127965 |
| 33 | MP0001905_abnormal_dopamine_level | 1.28158193 |
| 34 | MP0003718_maternal_effect | 1.27209048 |
| 35 | MP0002163_abnormal_gland_morphology | 1.27203737 |
| 36 | MP0009643_abnormal_urine_homeostasis | 1.26473366 |
| 37 | MP0001542_abnormal_bone_strength | 1.25844076 |
| 38 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.24911377 |
| 39 | MP0004147_increased_porphyrin_level | 1.22814561 |
| 40 | MP0000372_irregular_coat_pigmentation | 1.17750950 |
| 41 | MP0000343_altered_response_to | 1.17573024 |
| 42 | MP0004264_abnormal_extraembryonic_tissu | 1.15848719 |
| 43 | MP0003195_calcinosis | 1.15699284 |
| 44 | MP0006082_CNS_inflammation | 1.12651518 |
| 45 | MP0001958_emphysema | 1.10636232 |
| 46 | MP0002138_abnormal_hepatobiliary_system | 1.04907827 |
| 47 | MP0010030_abnormal_orbit_morphology | 0.99297653 |
| 48 | MP0005551_abnormal_eye_electrophysiolog | 0.99044590 |
| 49 | MP0002877_abnormal_melanocyte_morpholog | 0.97646023 |
| 50 | MP0005636_abnormal_mineral_homeostasis | 0.96679486 |
| 51 | MP0002118_abnormal_lipid_homeostasis | 0.94408352 |
| 52 | MP0002295_abnormal_pulmonary_circulatio | 0.93885160 |
| 53 | MP0000383_abnormal_hair_follicle | 0.90676521 |
| 54 | MP0005164_abnormal_response_to | 0.88654894 |
| 55 | MP0000639_abnormal_adrenal_gland | 0.85723958 |
| 56 | MP0004133_heterotaxia | 0.85703400 |
| 57 | MP0010678_abnormal_skin_adnexa | 0.84897975 |
| 58 | MP0000249_abnormal_blood_vessel | 0.84113984 |
| 59 | MP0000427_abnormal_hair_cycle | 0.83604844 |
| 60 | MP0003075_altered_response_to | 0.83518565 |
| 61 | MP0005395_other_phenotype | 0.82996459 |
| 62 | MP0006072_abnormal_retinal_apoptosis | 0.82111722 |
| 63 | MP0001853_heart_inflammation | 0.81314339 |
| 64 | MP0001756_abnormal_urination | 0.76532045 |
| 65 | MP0003283_abnormal_digestive_organ | 0.75816561 |
| 66 | MP0002148_abnormal_hypersensitivity_rea | 0.74100516 |
| 67 | MP0009780_abnormal_chondrocyte_physiolo | 0.73608871 |
| 68 | MP0003786_premature_aging | 0.72817550 |
| 69 | MP0000003_abnormal_adipose_tissue | 0.71131181 |
| 70 | MP0001664_abnormal_digestion | 0.70416651 |
| 71 | MP0006036_abnormal_mitochondrial_physio | 0.69837007 |
| 72 | MP0003806_abnormal_nucleotide_metabolis | 0.69396869 |
| 73 | MP0009642_abnormal_blood_homeostasis | 0.67308361 |
| 74 | MP0003186_abnormal_redox_activity | 0.66999563 |
| 75 | MP0002160_abnormal_reproductive_system | 0.65477329 |
| 76 | MP0002254_reproductive_system_inflammat | 0.64639991 |
| 77 | MP0002693_abnormal_pancreas_physiology | 0.64347529 |
| 78 | MP0002928_abnormal_bile_duct | 0.64157808 |
| 79 | MP0005330_cardiomyopathy | 0.63843781 |
| 80 | MP0003123_paternal_imprinting | 0.62242269 |
| 81 | MP0004142_abnormal_muscle_tone | 0.62217980 |
| 82 | MP0005220_abnormal_exocrine_pancreas | 0.62186470 |
| 83 | MP0005187_abnormal_penis_morphology | 0.61261409 |
| 84 | MP0008469_abnormal_protein_level | 0.60620734 |
| 85 | MP0002136_abnormal_kidney_physiology | 0.60215811 |
| 86 | MP0005166_decreased_susceptibility_to | 0.58353731 |
| 87 | MP0001764_abnormal_homeostasis | 0.57966340 |
| 88 | MP0000609_abnormal_liver_physiology | 0.57659265 |
| 89 | MP0004782_abnormal_surfactant_physiolog | 0.56975853 |
| 90 | MP0003936_abnormal_reproductive_system | 0.55026848 |
| 91 | MP0004484_altered_response_of | 0.55015640 |
| 92 | MP0002168_other_aberrant_phenotype | 0.54835790 |
| 93 | MP0004883_abnormal_blood_vessel | 0.54506270 |
| 94 | MP0005448_abnormal_energy_balance | 0.52408993 |
| 95 | MP0003045_fibrosis | 0.51552192 |
| 96 | MP0005389_reproductive_system_phenotype | 0.50911181 |
| 97 | MP0002557_abnormal_social/conspecific_i | 0.50792275 |
| 98 | MP0001881_abnormal_mammary_gland | 0.49249057 |
| 99 | MP0008995_early_reproductive_senescence | 0.48982383 |
| 100 | MP0001919_abnormal_reproductive_system | 0.48016384 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypobetalipoproteinemia (HP:0003563) | 7.00629456 |
| 2 | Hyperlipoproteinemia (HP:0010980) | 4.70629373 |
| 3 | Hypolipoproteinemia (HP:0010981) | 4.58535977 |
| 4 | Vacuolated lymphocytes (HP:0001922) | 4.40290452 |
| 5 | Entropion (HP:0000621) | 4.39487525 |
| 6 | Abnormality of glycolipid metabolism (HP:0010969) | 4.30999704 |
| 7 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.30999704 |
| 8 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.30999704 |
| 9 | Joint hemorrhage (HP:0005261) | 4.24761098 |
| 10 | Malnutrition (HP:0004395) | 3.94281314 |
| 11 | Amyloidosis (HP:0011034) | 3.84793997 |
| 12 | Glucose intolerance (HP:0000833) | 3.82432965 |
| 13 | Delayed CNS myelination (HP:0002188) | 3.58207151 |
| 14 | Prolonged neonatal jaundice (HP:0006579) | 3.47284366 |
| 15 | Type I transferrin isoform profile (HP:0003642) | 3.37464165 |
| 16 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.35176350 |
| 17 | Vascular calcification (HP:0004934) | 3.29594055 |
| 18 | Hyperglycinemia (HP:0002154) | 3.29273185 |
| 19 | Gout (HP:0001997) | 3.09884020 |
| 20 | Gingival bleeding (HP:0000225) | 3.07516313 |
| 21 | Unilateral renal agenesis (HP:0000122) | 3.05549141 |
| 22 | Hypoplasia of the uterus (HP:0000013) | 3.05298008 |
| 23 | Pigmentary retinal degeneration (HP:0001146) | 3.03984901 |
| 24 | Abnormality of the common coagulation pathway (HP:0010990) | 3.03884200 |
| 25 | Abnormality of the prostate (HP:0008775) | 3.02584672 |
| 26 | Reduced antithrombin III activity (HP:0001976) | 2.95209724 |
| 27 | J-shaped sella turcica (HP:0002680) | 2.93606174 |
| 28 | Abnormal protein glycosylation (HP:0012346) | 2.92090224 |
| 29 | Abnormal glycosylation (HP:0012345) | 2.92090224 |
| 30 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.92090224 |
| 31 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.92090224 |
| 32 | Ureteral stenosis (HP:0000071) | 2.91754222 |
| 33 | Ureteral obstruction (HP:0006000) | 2.83906559 |
| 34 | Prolonged partial thromboplastin time (HP:0003645) | 2.80945127 |
| 35 | Cardiovascular calcification (HP:0011915) | 2.76184397 |
| 36 | Abnormality of macrophages (HP:0004311) | 2.74716962 |
| 37 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.72652946 |
| 38 | Dysostosis multiplex (HP:0000943) | 2.71255799 |
| 39 | Nuclear cataract (HP:0100018) | 2.68771405 |
| 40 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.68388643 |
| 41 | Late onset (HP:0003584) | 2.63207879 |
| 42 | Abnormality of magnesium homeostasis (HP:0004921) | 2.63086616 |
| 43 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.60607044 |
| 44 | Severe visual impairment (HP:0001141) | 2.56044800 |
| 45 | Tubulointerstitial nephritis (HP:0001970) | 2.49725987 |
| 46 | Abnormal pancreas size (HP:0012094) | 2.49469652 |
| 47 | Abnormal glucose tolerance (HP:0001952) | 2.47856179 |
| 48 | Menorrhagia (HP:0000132) | 2.47423943 |
| 49 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.42072078 |
| 50 | Hypomagnesemia (HP:0002917) | 2.42017623 |
| 51 | Abnormality of male internal genitalia (HP:0000022) | 2.37261623 |
| 52 | Type 2 muscle fiber atrophy (HP:0003554) | 2.34709988 |
| 53 | Hypoalphalipoproteinemia (HP:0003233) | 2.33114633 |
| 54 | Nausea (HP:0002018) | 2.29051979 |
| 55 | Mitral stenosis (HP:0001718) | 2.28948252 |
| 56 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.23310113 |
| 57 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.23310113 |
| 58 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.23310113 |
| 59 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.23277113 |
| 60 | Mucopolysacchariduria (HP:0008155) | 2.23277113 |
| 61 | Muscle fiber atrophy (HP:0100295) | 2.22266058 |
| 62 | Pancreatitis (HP:0001733) | 2.14135875 |
| 63 | Beaking of vertebral bodies (HP:0004568) | 2.11589613 |
| 64 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.03554292 |
| 65 | Cholecystitis (HP:0001082) | 2.01467049 |
| 66 | Abnormal gallbladder physiology (HP:0012438) | 2.01467049 |
| 67 | Ectropion (HP:0000656) | 2.01164102 |
| 68 | Acute encephalopathy (HP:0006846) | 2.00664795 |
| 69 | Retinal atrophy (HP:0001105) | 1.98834086 |
| 70 | Stage 5 chronic kidney disease (HP:0003774) | 1.97177260 |
| 71 | Poikiloderma (HP:0001029) | 1.96206768 |
| 72 | Hypokinesia (HP:0002375) | 1.95446840 |
| 73 | Abnormality of nucleobase metabolism (HP:0010932) | 1.95171591 |
| 74 | Opisthotonus (HP:0002179) | 1.92864428 |
| 75 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.92333308 |
| 76 | Hepatosplenomegaly (HP:0001433) | 1.90692703 |
| 77 | Male infertility (HP:0003251) | 1.88569036 |
| 78 | Tubular atrophy (HP:0000092) | 1.87660374 |
| 79 | Distal lower limb muscle weakness (HP:0009053) | 1.87084733 |
| 80 | Congenital sensorineural hearing impairment (HP:0008527) | 1.86721069 |
| 81 | Cardiomegaly (HP:0001640) | 1.86472437 |
| 82 | Petechiae (HP:0000967) | 1.85869690 |
| 83 | Severe muscular hypotonia (HP:0006829) | 1.83777287 |
| 84 | Increased purine levels (HP:0004368) | 1.83484054 |
| 85 | Hyperuricemia (HP:0002149) | 1.83484054 |
| 86 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.83481074 |
| 87 | Patchy hypopigmentation of hair (HP:0011365) | 1.80492047 |
| 88 | Microretrognathia (HP:0000308) | 1.78915132 |
| 89 | Tetany (HP:0001281) | 1.77367213 |
| 90 | Adrenal hypoplasia (HP:0000835) | 1.76762732 |
| 91 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.76647302 |
| 92 | Abnormality of glycine metabolism (HP:0010895) | 1.76647302 |
| 93 | Increased serum ferritin (HP:0003281) | 1.75974548 |
| 94 | Joint swelling (HP:0001386) | 1.73511334 |
| 95 | Vertebral compression fractures (HP:0002953) | 1.73026378 |
| 96 | Bicornuate uterus (HP:0000813) | 1.72089663 |
| 97 | Progressive neurologic deterioration (HP:0002344) | 1.71705275 |
| 98 | Zonular cataract (HP:0010920) | 1.70314017 |
| 99 | Acute necrotizing encephalopathy (HP:0006965) | 1.69744897 |
| 100 | Hyperglycinuria (HP:0003108) | 1.69428877 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MUSK | 7.07517316 |
| 2 | PIK3CG | 5.83849874 |
| 3 | MAP3K12 | 4.77177152 |
| 4 | EPHA2 | 4.21476167 |
| 5 | TESK2 | 4.18645440 |
| 6 | BCKDK | 3.40222854 |
| 7 | MYLK | 2.74511951 |
| 8 | BLK | 2.48477711 |
| 9 | TXK | 1.97709802 |
| 10 | MST4 | 1.86411293 |
| 11 | VRK2 | 1.62825334 |
| 12 | ARAF | 1.58984833 |
| 13 | NME1 | 1.57696322 |
| 14 | NME2 | 1.53436340 |
| 15 | PIM2 | 1.51863594 |
| 16 | DAPK1 | 1.46908694 |
| 17 | CASK | 1.44453607 |
| 18 | NEK1 | 1.38557802 |
| 19 | LMTK2 | 1.38237956 |
| 20 | ZAP70 | 1.32458153 |
| 21 | ABL2 | 1.25186878 |
| 22 | RIPK1 | 1.24912193 |
| 23 | MST1R | 1.24270819 |
| 24 | MAP3K3 | 1.23858898 |
| 25 | KDR | 1.20371392 |
| 26 | BCR | 1.18434909 |
| 27 | PAK4 | 1.17369129 |
| 28 | SIK3 | 1.10764421 |
| 29 | MET | 0.98631106 |
| 30 | TESK1 | 0.97665736 |
| 31 | LIMK1 | 0.93593919 |
| 32 | GRK6 | 0.89456217 |
| 33 | PTK2 | 0.87652664 |
| 34 | DAPK3 | 0.85628591 |
| 35 | PBK | 0.85420177 |
| 36 | PRKCE | 0.84156172 |
| 37 | GRK5 | 0.83125882 |
| 38 | TRIM28 | 0.82854238 |
| 39 | CDK19 | 0.80725131 |
| 40 | SCYL2 | 0.75510364 |
| 41 | ERN1 | 0.74759601 |
| 42 | TNIK | 0.73635066 |
| 43 | MAP3K2 | 0.73588128 |
| 44 | CSF1R | 0.71998399 |
| 45 | STK10 | 0.65854515 |
| 46 | BMPR1B | 0.65440405 |
| 47 | CSNK1G2 | 0.64622452 |
| 48 | ADRBK2 | 0.63349081 |
| 49 | TLK1 | 0.62890019 |
| 50 | LRRK2 | 0.60238984 |
| 51 | BUB1 | 0.60058003 |
| 52 | GRK1 | 0.58794758 |
| 53 | PTK2B | 0.57905957 |
| 54 | PHKG2 | 0.57514126 |
| 55 | PHKG1 | 0.57514126 |
| 56 | DAPK2 | 0.57367895 |
| 57 | CSNK1G3 | 0.55251697 |
| 58 | OXSR1 | 0.55115850 |
| 59 | EIF2AK1 | 0.54151658 |
| 60 | ILK | 0.52838307 |
| 61 | PRKCI | 0.51597077 |
| 62 | MAP2K6 | 0.48815133 |
| 63 | TGFBR2 | 0.48662676 |
| 64 | ACVR1B | 0.47980317 |
| 65 | NUAK1 | 0.47512310 |
| 66 | WNK4 | 0.45376245 |
| 67 | RPS6KA4 | 0.43481818 |
| 68 | PINK1 | 0.43116224 |
| 69 | PRKCQ | 0.42727218 |
| 70 | CSNK1A1L | 0.41981069 |
| 71 | WNK3 | 0.41071914 |
| 72 | MAPKAPK3 | 0.41001145 |
| 73 | STK24 | 0.39526013 |
| 74 | TRPM7 | 0.38078609 |
| 75 | ERBB4 | 0.36625198 |
| 76 | MAPK11 | 0.36505462 |
| 77 | FLT3 | 0.35746279 |
| 78 | IKBKB | 0.35485808 |
| 79 | ERBB3 | 0.35280788 |
| 80 | GRK7 | 0.35271584 |
| 81 | VRK1 | 0.34983829 |
| 82 | CSNK1G1 | 0.32497300 |
| 83 | CAMK2G | 0.32240950 |
| 84 | PRKACB | 0.31941563 |
| 85 | EGFR | 0.30606244 |
| 86 | EPHB1 | 0.28717110 |
| 87 | RPS6KA5 | 0.27144223 |
| 88 | CCNB1 | 0.26505786 |
| 89 | ABL1 | 0.26503815 |
| 90 | HIPK2 | 0.25912955 |
| 91 | EPHB2 | 0.25883569 |
| 92 | TAF1 | 0.25524028 |
| 93 | ITK | 0.25291272 |
| 94 | MARK3 | 0.22583250 |
| 95 | MAP3K9 | 0.22461980 |
| 96 | TBK1 | 0.21669709 |
| 97 | ROCK1 | 0.20533163 |
| 98 | PAK1 | 0.20225099 |
| 99 | AKT2 | 0.20208725 |
| 100 | PRKCA | 0.18607006 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Galactose metabolism_Homo sapiens_hsa00052 | 4.10228133 |
| 2 | Asthma_Homo sapiens_hsa05310 | 4.00719458 |
| 3 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 3.93282613 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.94734440 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 2.81306527 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.61192024 |
| 7 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.50245578 |
| 8 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.44248063 |
| 9 | Mineral absorption_Homo sapiens_hsa04978 | 2.26935668 |
| 10 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.17194881 |
| 11 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.16557792 |
| 12 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.14824597 |
| 13 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.03378906 |
| 14 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 2.01097490 |
| 15 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.98314544 |
| 16 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.76706956 |
| 17 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.74267864 |
| 18 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.71859317 |
| 19 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.70686352 |
| 20 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.68232214 |
| 21 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.64007919 |
| 22 | Proteasome_Homo sapiens_hsa03050 | 1.55111563 |
| 23 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.54722714 |
| 24 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.53547851 |
| 25 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.53474151 |
| 26 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.52893373 |
| 27 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.51654923 |
| 28 | Phototransduction_Homo sapiens_hsa04744 | 1.51612416 |
| 29 | Other glycan degradation_Homo sapiens_hsa00511 | 1.49930182 |
| 30 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.45445136 |
| 31 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.45350526 |
| 32 | Viral myocarditis_Homo sapiens_hsa05416 | 1.38358147 |
| 33 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.36350902 |
| 34 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.35370011 |
| 35 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.34115411 |
| 36 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.33038912 |
| 37 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.23194615 |
| 38 | Parkinsons disease_Homo sapiens_hsa05012 | 1.14143128 |
| 39 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.09922638 |
| 40 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.07686114 |
| 41 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.03253612 |
| 42 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.02565189 |
| 43 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.02441824 |
| 44 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.98066248 |
| 45 | Carbon metabolism_Homo sapiens_hsa01200 | 0.90262210 |
| 46 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.87048722 |
| 47 | Lysosome_Homo sapiens_hsa04142 | 0.87047412 |
| 48 | Homologous recombination_Homo sapiens_hsa03440 | 0.84441456 |
| 49 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.81828419 |
| 50 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.81528432 |
| 51 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.79972461 |
| 52 | Alzheimers disease_Homo sapiens_hsa05010 | 0.77592554 |
| 53 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.75967605 |
| 54 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.75044364 |
| 55 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.73764725 |
| 56 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.72897767 |
| 57 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.71784465 |
| 58 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.71368639 |
| 59 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.70807607 |
| 60 | Huntingtons disease_Homo sapiens_hsa05016 | 0.70730683 |
| 61 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.70438037 |
| 62 | Circadian rhythm_Homo sapiens_hsa04710 | 0.70379130 |
| 63 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.67945133 |
| 64 | Leishmaniasis_Homo sapiens_hsa05140 | 0.66413226 |
| 65 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.64770115 |
| 66 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.63375896 |
| 67 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.62704969 |
| 68 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.62539375 |
| 69 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.61949071 |
| 70 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.61146906 |
| 71 | Metabolic pathways_Homo sapiens_hsa01100 | 0.61114764 |
| 72 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.60157022 |
| 73 | Retinol metabolism_Homo sapiens_hsa00830 | 0.56606663 |
| 74 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.55999513 |
| 75 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.55957440 |
| 76 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.55810045 |
| 77 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.51619689 |
| 78 | Peroxisome_Homo sapiens_hsa04146 | 0.51411934 |
| 79 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.49041550 |
| 80 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.48249346 |
| 81 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.47778991 |
| 82 | Phagosome_Homo sapiens_hsa04145 | 0.45277481 |
| 83 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.40800589 |
| 84 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.40167386 |
| 85 | Bile secretion_Homo sapiens_hsa04976 | 0.38708792 |
| 86 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.37758010 |
| 87 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.37389847 |
| 88 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.36521188 |
| 89 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.35129615 |
| 90 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.35092640 |
| 91 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.34843067 |
| 92 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.33474120 |
| 93 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.31302008 |
| 94 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.30400814 |
| 95 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.30267150 |
| 96 | Tuberculosis_Homo sapiens_hsa05152 | 0.30009761 |
| 97 | Purine metabolism_Homo sapiens_hsa00230 | 0.27721517 |
| 98 | Salmonella infection_Homo sapiens_hsa05132 | 0.26557607 |
| 99 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.25534530 |
| 100 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.25134173 |

